Comprehensive Real-Time News Feed for EntreMed.
Results 1 - 2 of 2 in EntreMed
Recently published research from MarketLine, "EntreMed, Inc. - Mergers & Acquisitions , Partnerships & Alliances and Investment Report", is now available at Fast Market Research MarketLine's Company Mergers & Acquisitions , Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EntreMed, Inc. Mergers & Acquisitions , Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions , divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by EntreMed, Inc. since January 2007. Comment?
... October 29th. They set a "buy" rating and a $3.00 price objective on the stock. CASI Pharmaceuticals Inc, formerly EntreMed, Inc., is a clinical-stage pharmaceutical company. Its drug candidate is ENMD-2076, an Aurora A and angiogenic kinase ... Comment?
- « Previous
- Next »
Copyright © 2016 Topix LLC